Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Insulin Resistance and Accelerated Cognitive Aging

Authors not listed

Stanford University · 2017

Abstract

Premature and accelerated brain aging trajectories have been observed among people with metabolic dysfunction, but mechanisms of these altered trajectories are not understood. Insulin resistance (IR) is known to change with age and affect cognition in older and elderly adults as well as in patients with mood disorders. The main purpose of the study is to describe the developmental trajectory of cognitive and neural biomarkers across the spectrum of metabolic dysfunction in overweight/obese adults younger than 50 years of age. The innovative study design will allow the investigators to examine cognitive outcome development over a 25-year span without an investment into the longitudinal observation of changes in cognition and neural function.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-20 MST

Cite this

APA
Anonymous. (2017). Insulin Resistance and Accelerated Cognitive Aging. <em>Stanford University</em>. https://clinicaltrials.gov/study/NCT03039647
Vancouver
Anonymous. Insulin Resistance and Accelerated Cognitive Aging. Stanford University. 2017.
BibTeX
@misc{anon2017Insuli, title = {Insulin Resistance and Accelerated Cognitive Aging}, author = {Anonymous}, journal = {Stanford University}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings